Two new families with X-linked inhibitor of apoptosis deficiency and a review of all 26 published cases - 10/08/11
Doi : 10.1016/j.jaci.2010.11.040
Peter C. Horn, MD a, c, Bernd H. Belohradsky, MD d, Christian Urban, MD e, Daniela Weber-Mzell, MD e, Alfons Meindl, PhD b, Volker Schuster, MD f 
a Department of Medicine, Technical University of Munich, Munich, Germany
b Department of Obstetrics and Gynecology, Technical University of Munich, Munich, Germany
c Department of Ophthalmology, University of Freiburg, Germany
d University Children’s, Ludwig-Maximilians University Munich, Munich, Germany
e Division of Pediatric Hematology/Oncology, Department of Pediatrics and Adolescent Medicine, Medical University of Graz, Austria
f Hospital for Children and Adolescents, University of Leipzig, Germany
| Supported in part by a grant of the Medical Faculty of Leipzig to V.S. (grant no. 78261 101). |
|
| Disclosure of potential conflict of interest: The authors have declared that they have no conflict of interest. |
© 2010
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 127 - N° 2
P. 544-546 - février 2011 Retour au numéro
Article précédent
- Hodgkin lymphoma in 2 children with chronic granulomatous disease
- Saul Oswaldo Lugo Reyes, Felipe Suarez, Rose-Marie Herbigneaux, Hélène Pacquement, Yves Réguerre, Jean-Pierre Rivière, Maylis de Suremain, Yoann Rose, Jacqueline Feinberg, Nizar Malahoui, Alain Fischer, Stéphane Blanche, Jean-Laurent Casanova, Capucine Picard, Jacinta Bustamante
- Moderately complex US Food and Drug Administration–cleared method for human IgE antibody serology
- Vivian Saper
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?